Myomo Reports First Quarter 2026 Financial and Operating Results
Myomo, Inc. reported its financial results for the first quarter of 2026, focusing on its efforts to support individuals with neurological disorders and upper-limb paralysis through wearable medical robotics. The company outlined its strategic goals for the year, which include increasing revenue from recurrent patient sources, enhancing market accessibility, and demonstrating operational leverage.
BURLINGTON, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months ended March 31, 2026. “Earlier this year we established four success pillars for 2026, including growing revenue from recurring patient sources, increasing market access, demonstrating operating leverag